Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Dowling

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Pharmacology|October 6, 2011
The in vitro metabolism of sphingosine-1-phosphate: identification; inhibition and pharmacological implicationsMichelle E Bradley, Neil McGuinness, Gareth Williams, et al.
The Medical Journal of Australia|May 26, 2022
Strongyloides hyperinfection: a preventable complication of immunosuppressionRobert G Stolz, Mark R Dowling, Belinda B Lin, et al.
Plos One|March 19, 2013
A model for studying the hemostatic consumption or destruction of plateletsMark R Dowling, Emma C Josefsson, Katya J Henley, et al.
Blood|June 10, 2010
Platelet senescence is regulated by an internal timer, not damage inflicted by hitsMark R Dowling, Emma C Josefsson, Katya J Henley, et al.
Frontiers in Immunology|November 15, 2018
Regulatory T Cells Suppress Effector T Cell Proliferation by Limiting Division DestinyMark R Dowling, Andrey Kan, Susanne Heinzel, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 21, 2006
A single point mutation (N514Y) in the human M3 muscarinic acetylcholine receptor reveals differences in the properties of antagonists: evidence for differential inverse agonismMark R Dowling, Jonathon M Willets, David C Budd, et al.
Current Opinion in Pharmacology|April 1, 2014
The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder diseasePhilippa R Dale, Hana Cernecka, Martina Schmidt, et al.
Plos One|January 10, 2014
Labour-efficient in vitro lymphocyte population tracking and fate prediction using automation and manual reviewRajib Chakravorty, David Rawlinson, Alan Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2012
The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropiumDavid A Sykes, Mark R Dowling, Juliet Leighton-Davies, et al.
Plos One|January 8, 2016
Stochastic Measurement Models for Quantifying Lymphocyte Responses Using Flow CytometryAndrey Kan, Damian Pavlyshyn, John F Markham, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Pharmacology|October 6, 2011
The in vitro metabolism of sphingosine-1-phosphate: identification; inhibition and pharmacological implicationsMichelle E Bradley, Neil McGuinness, Gareth Williams, et al.
The Medical Journal of Australia|May 26, 2022
Strongyloides hyperinfection: a preventable complication of immunosuppressionRobert G Stolz, Mark R Dowling, Belinda B Lin, et al.
Plos One|March 19, 2013
A model for studying the hemostatic consumption or destruction of plateletsMark R Dowling, Emma C Josefsson, Katya J Henley, et al.
Blood|June 10, 2010
Platelet senescence is regulated by an internal timer, not damage inflicted by hitsMark R Dowling, Emma C Josefsson, Katya J Henley, et al.
Frontiers in Immunology|November 15, 2018
Regulatory T Cells Suppress Effector T Cell Proliferation by Limiting Division DestinyMark R Dowling, Andrey Kan, Susanne Heinzel, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 21, 2006
A single point mutation (N514Y) in the human M3 muscarinic acetylcholine receptor reveals differences in the properties of antagonists: evidence for differential inverse agonismMark R Dowling, Jonathon M Willets, David C Budd, et al.
Current Opinion in Pharmacology|April 1, 2014
The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder diseasePhilippa R Dale, Hana Cernecka, Martina Schmidt, et al.
Plos One|January 10, 2014
Labour-efficient in vitro lymphocyte population tracking and fate prediction using automation and manual reviewRajib Chakravorty, David Rawlinson, Alan Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2012
The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropiumDavid A Sykes, Mark R Dowling, Juliet Leighton-Davies, et al.
Plos One|January 8, 2016
Stochastic Measurement Models for Quantifying Lymphocyte Responses Using Flow CytometryAndrey Kan, Damian Pavlyshyn, John F Markham, et al.
Pageof 6